Literature DB >> 8244577

Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach.

M J Blaser1, K Kobayashi, T L Cover, P Cao, I D Feurer, G I Pérez-Pérez.   

Abstract

To examine the association of Helicobacter pylori infection with adenocarcinoma of the stomach in Japanese patients, we studied 29 patients and 58 matched controls. Ascertainment of H. pylori status was based on the presence of specific IgG to H. pylori. For the entire group, an association of this infection with gastric adenocarcinoma was suggested but not statistically significant. For patients in a putatively high-risk subgroup (non-cardia tumors and age < or = 70 years), the association was significant. Assays detecting serum IgA to whole H. pylori cells and cytotoxin, IgG to cytotoxin and Hp54K (the heat-shock protein homolog) and serum neutralization of cytotoxin activity each showed clear differences between H. pylori-infected and uninfected persons in this population. However, for none of these assays was there a significant difference between values for H. pylori-infected persons with or without gastric cancer. Thus, while H. pylori infection was associated with non-cardia gastric cancer in Japanese persons < or = 70 years of age, use of these additional serologic markers did not define additional factors that might be associated with increased risk.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244577     DOI: 10.1002/ijc.2910550518

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Stool Antigen Testing, a Reliable Noninvasive Method of Assessment of Helicobacter pylori Infection Among Patients with Gastro-duodenal Disorders in Cameroon.

Authors:  Laure Brigitte Kouitcheu Mabeku; Mohamadou Bello Epesse; Stephane Fotsing; Roland Kamgang; Magloire Tchidjo
Journal:  Dig Dis Sci       Date:  2020-04-30       Impact factor: 3.199

2.  Intracellular Helicobacter pylori and gastric carcinogenesis: an "old" frontier worth revisiting.

Authors:  Andre Dubois
Journal:  Gastroenterology       Date:  2007-03       Impact factor: 22.682

Review 3.  Diet, H pylori infection and gastric cancer: evidence and controversies.

Authors:  Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

4.  Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis.

Authors:  S Ito; T Azuma; H Murakita; M Hirai; H Miyaji; Y Ito; Y Ohtaki; Y Yamazaki; M Kuriyama; Y Keida; Y Kohli
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

5.  Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.

Authors:  Y Watanabe; J H Kurata; S Mizuno; M Mukai; H Inokuchi; K Miki; K Ozasa; K Kawai
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

6.  Helicobacter pylori and mucosal atrophy in patients with gastric cancer: a special study regarding the methods for detecting Helicobacter pylori.

Authors:  H Tabata; T Fuchigami; H Kobayashi; Y Sakai; M Nakanishi; K Tomioka; S Nakamura; M Fujishima
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

7.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Authors:  H Watabe; T Mitsushima; Y Yamaji; M Okamoto; R Wada; T Kokubo; H Doi; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

8.  Helicobacter mesocricetorum sp. nov., A novel Helicobacter isolated from the feces of Syrian hamsters.

Authors:  J H Simmons; L K Riley; C L Besch-Williford; C L Franklin
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

9.  Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up.

Authors:  W V Harford; C Barnett; E Lee; G Perez-Perez; M J Blaser; W L Peterson
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

10.  Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.

Authors:  H Miyaji; S Ito; T Azuma; Y Ito; Y Yamazaki; Y Ohtaki; F Sato; M Hirai; M Kuriyama; Y Kohli
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.